Chemokines, cytokines and exosomes help tumors to shape inflammatory microenvironment

Pharmacology and Therapeutics

Volumn 168, Issue , 2016, Pages 98-112

  Atretkhany, K S N ^a,b   Drutskaya, M S ^a,b   Nedospasov, S A ^a,b,c   Grivennikov, S I ^a,d   Kuprash, D V ^a,b  

^a ENGELHARDT INSTITUTE OF MOLECULAR BIOLOGY   (Russian Federation)

^b MOSCOW STATE UNIVERSITY   (Russian Federation)

^c DEUTSCHES RHEUMA FORSCHUNGSZENTRUM   (Germany)

^d FOX CHASE CANCER CENTER   (United States)

Author keywords

Cancer; Chemokines; Cytokines; Exosomes; Inflammation; Tumor

Indexed keywords

CHEMOKINE; CYTOKINE;

BONE MARROW CELL; CANCER RESISTANCE; CARCINOGENESIS; CELL DEATH; CELL MIGRATION; ENVIRONMENTAL FACTOR; EXOSOME; HUMAN; IMMUNE SYSTEM; IMMUNOCOMPETENT CELL; IMMUNOGENICITY; INFLAMMATION; INTRACELLULAR SIGNALING; MACROPHAGE; MYELOID DERIVED SUPPRESSOR CELL; NEUTROPHIL; NONHUMAN; PRIORITY JOURNAL; REVIEW; SUPPRESSOR CELL; T LYMPHOCYTE SUBPOPULATION; TUMOR MICROENVIRONMENT; TUMOR PROMOTION; TUMOR REGRESSION; ANIMAL; DISEASE COURSE; IMMUNOLOGY; METABOLISM; NEOPLASM; PATHOLOGY;

ANIMALS; CHEMOKINES; CYTOKINES; DISEASE PROGRESSION; EXOSOMES; HUMANS; INFLAMMATION; NEOPLASMS; TUMOR MICROENVIRONMENT;

EID: 84999274251     PISSN: 01637258     EISSN: 1879016X     Source Type: Journal    
DOI: 10.1016/j.pharmthera.2016.09.011     Document Type: Review

References (268)

1. Abusamra, A.J., Zhong, Z., Zheng, X., Li, M., Ichim, T.E., Chin, J.L., Min, W.P., Tumor exosomes expressing Fas ligand mediate CD8 + T-cell apoptosis. Blood Cells Mol Dis 35 (2005), 169–173.
2. Aggarwal, B.B., Gupta, S.C., Kim, J.H., Historical perspectives on tumor necrosis factor and its superfamily: 25 years later, a golden journey. Blood 119 (2012), 651–665.
3. Alam, R., Stafford, S., Forsythe, P., Harrison, R., Faubion, D., Lett-Brown, M.A., Grant, J.A., RANTES is a chemotactic and activating factor for human eosinophils. J Immunol 150 (1993), 3442–3448.
4. Albina, J.E., Mastrofrancesco, B., Vessella, J.A., Louis, C.A., Henry, W.L. Jr., Reichner, J.S., HIF-1 expression in healing wounds: HIF-1alpha induction in primary inflammatory cells by TNF-alpha. Am J Physiol Cell Physiol 281 (2001), C1971–C1977.
5. Ammirante, M., Luo, J.L., Grivennikov, S., Nedospasov, S., Karin, M., B-cell-derived lymphotoxin promotes castration-resistant prostate cancer. Nature 464 (2010), 302–305.
6. Apte, R.N., Dotan, S., Elkabets, M., White, M.R., Reich, E., Carmi, Y.,.. Voronov, E., The involvement of IL-1 in tumorigenesis, tumor invasiveness, metastasis and tumor-host interactions. Cancer Metastasis Rev 25 (2006), 387–408.
7. Atretkhany, K.S., Nosenko, M.A., Gogoleva, V.S., Zvartsev, R.V., Qin, Z., Nedospasov, S.A., Drutskaya, M.S., TNF neutralization results in the delay of transplantable tumor growth and reduced MDSC accumulation. Front Immunol, 7, 2016, 147.
8. Azenshtein, E., Meshel, T., Shina, S., Barak, N., Keydar, I., Ben-Baruch, A., The angiogenic factors CXCL8 and VEGF in breast cancer: regulation by an array of pro-malignancy factors. Cancer Lett 217 (2005), 73–86.
9. Bachelder, R.E., Wendt, M.A., Mercurio, A.M., Vascular endothelial growth factor promotes breast carcinoma invasion in an autocrine manner by regulating the chemokine receptor CXCR4. Cancer Res 62 (2002), 7203–7206.
10. Bailey, S.R., Nelson, M.H., Himes, R.A., Li, Z., Mehrotra, S., Paulos, C.M., Th17 cells in cancer: the ultimate identity crisis. Front Immunol, 5, 2014, 276.
11. Balkwill, F., The significance of cancer cell expression of the chemokine receptor CXCR4. Semin Cancer Biol 14 (2004), 171–179.
12. Balkwill, F., Tumour necrosis factor and cancer. Nat Rev Cancer 9 (2009), 361–371.
13. Baratelli, F., Lee, J.M., Hazra, S., Lin, Y., Walser, T.C., Schaue, D.,.. Dubinett, S.M., PGE(2) contributes to TGF-beta induced T regulatory cell function in human non-small cell lung cancer. Am J Transl Res 2 (2010), 356–367.
14. Barretina, J., Caponigro, G., Stransky, N., Venkatesan, K., Margolin, A.A., Kim, S.,.. Garraway, L.A., The Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivity. Nature 483 (2012), 603–607.
15. Barsoum, I.B., Smallwood, C.A., Siemens, D.R., Graham, C.H., A mechanism of hypoxia-mediated escape from adaptive immunity in cancer cells. Cancer Res 74 (2014), 665–674.
16. Bayne, L.J., Beatty, G.L., Jhala, N., Clark, C.E., Rhim, A.D., Stanger, B.Z., Vonderheide, R.H., Tumor-derived granulocyte-macrophage colony-stimulating factor regulates myeloid inflammation and T cell immunity in pancreatic cancer. Cancer Cell 21 (2012), 822–835.
17. Bekes, E.M., Schweighofer, B., Kupriyanova, T.A., Zajac, E., Ardi, V.C., Quigley, J.P., Deryugina, E.I., Tumor-recruited neutrophils and neutrophil TIMP-free MMP-9 regulate coordinately the levels of tumor angiogenesis and efficiency of malignant cell intravasation. Am J Pathol 179 (2011), 1455–1470.
18. Belkaid, Y., Hand, T.W., Role of the microbiota in immunity and inflammation. Cell 157 (2014), 121–141.
19. Benevides, L., da Fonseca, D.M., Donate, P.B., Tiezzi, D.G., De Carvalho, D.D., de Andrade, J.M.,.. Silva, J.S., IL17 promotes mammary tumor progression by changing the behavior of tumor cells and eliciting tumorigenic neutrophils recruitment. Cancer Res 75 (2015), 3788–3799.
20. Bennewith, K.L., Dedhar, S., Targeting hypoxic tumour cells to overcome metastasis. BMC Cancer, 11, 2011, 504.
21. Bindea, G., Mlecnik, B., Tosolini, M., Kirilovsky, A., Waldner, M., Obenauf, A.C.,.. Galon, J., Spatiotemporal dynamics of intratumoral immune cells reveal the immune landscape in human cancer. Immunity 39 (2013), 782–795.
22. Boyle, S.T., Ingman, W.V., Poltavets, V., Faulkner, J.W., Whitfield, R.J., McColl, S.R., Kochetkova, M., The chemokine receptor CCR7 promotes mammary tumorigenesis through amplification of stem-like cells. Oncogene 35 (2016), 105–115.
23. Bretz, N.P., Ridinger, J., Rupp, A.K., Rimbach, K., Keller, S., Rupp, C.,.. Altevogt, P., Body fluid exosomes promote secretion of inflammatory cytokines in monocytic cells via Toll-like receptor signaling. J Biol Chem 288 (2013), 36691–36702.
24. Bronte, V., Serafini, P., Apolloni, E., Zanovello, P., Tumor-induced immune dysfunctions caused by myeloid suppressor cells. J Immunother 24 (2001), 431–446.
25. Burger, J.A., Peled, A., CXCR4 antagonists: targeting the microenvironment in leukemia and other cancers. Leukemia 23 (2009), 43–52.
26. Calon, A., Espinet, E., Palomo-Ponce, S., Tauriello, D.V., Iglesias, M., Cespedes, M.V.,.. Batlle, E., Dependency of colorectal cancer on a TGF-beta-driven program in stromal cells for metastasis initiation. Cancer Cell 22 (2012), 571–584.
27. Cao, Q., Wang, Y., Zheng, D., Sun, Y., Wang, Y., Lee, V.W.,.. Harris, D.C., IL-10/TGF-beta-modified macrophages induce regulatory T cells and protect against adriamycin nephrosis. J Am Soc Nephrol 21 (2010), 933–942.
28. Carswell, E.A., Old, L.J., Kassel, R.L., Green, S., Fiore, N., Williamson, B., An endotoxin-induced serum factor that causes necrosis of tumors. Proc Natl Acad Sci U S A 72 (1975), 3666–3670.
29. Casares, N., Pequignot, M.O., Tesniere, A., Ghiringhelli, F., Roux, S., Chaput, N.,.. Kroemer, G., Caspase-dependent immunogenicity of doxorubicin-induced tumor cell death. J Exp Med 202 (2005), 1691–1701.
30. Ceelen, W., Pattyn, P., Mareel, M., Surgery, wound healing, and metastasis: recent insights and clinical implications. Crit Rev Oncol Hematol 89 (2014), 16–26.
31. Chalmin, F., Ladoire, S., Mignot, G., Vincent, J., Bruchard, M., Remy-Martin, J.P.,.. Ghiringhelli, F., Membrane-associated Hsp72 from tumor-derived exosomes mediates STAT3-dependent immunosuppressive function of mouse and human myeloid-derived suppressor cells. J Clin Invest 120 (2010), 457–471.
32. Chen, D., Li, W., Liu, S., Su, Y., Han, G., Xu, C.,.. Mao, C., Interleukin-23 promotes the epithelial-mesenchymal transition of oesophageal carcinoma cells via the Wnt/beta-catenin pathway. Sci Rep, 5, 2015, 8604.
33. Chen, M.F., Kuan, F.C., Yen, T.C., Lu, M.S., Lin, P.Y., Chung, Y.H.,.. Lee, K.D., IL-6-stimulated CD11b + CD14 + HLA-DR- myeloid-derived suppressor cells, are associated with progression and poor prognosis in squamous cell carcinoma of the esophagus. Oncotarget 5 (2014), 8716–8728.
34. Chen, M.L., Pittet, M.J., Gorelik, L., Flavell, R.A., Weissleder, R., von Boehmer, H., Khazaie, K., Regulatory T cells suppress tumor-specific CD8 T cell cytotoxicity through TGF-beta signals in vivo. Proc Natl Acad Sci U S A 102 (2005), 419–424.
35. Chen, W.X., Liu, X.M., Lv, M.M., Chen, L., Zhao, J.H., Zhong, S.L.,.. Tang, J.H., Exosomes from drug-resistant breast cancer cells transmit chemoresistance by a horizontal transfer of microRNAs. PLoS One, 9, 2014, e95240.
36. Cheng, P., Corzo, C.A., Luetteke, N., Yu, B., Nagaraj, S., Bui, M.M.,.. Gabrilovich, D.I., Inhibition of dendritic cell differentiation and accumulation of myeloid-derived suppressor cells in cancer is regulated by S100A9 protein. J Exp Med 205 (2008), 2235–2249.
37. Chopra, M., Riedel, S.S., Biehl, M., Krieger, S., von Krosigk, V., Bauerlein, C.A.,.. Beilhack, A., Tumor necrosis factor receptor 2-dependent homeostasis of regulatory T cells as a player in TNF-induced experimental metastasis. Carcinogenesis 34 (2013), 1296–1303.
38. Chow, A., Zhou, W., Liu, L., Fong, M.Y., Champer, J., Van Haute, D.,.. Wang, S.E., Macrophage immunomodulation by breast cancer-derived exosomes requires Toll-like receptor 2-mediated activation of NF-kappaB. Sci Rep, 4, 2014, 5750.
39. Chung, A.S., Wu, X., Zhuang, G., Ngu, H., Kasman, I., Zhang, J.,.. Ferrara, N., An interleukin-17-mediated paracrine network promotes tumor resistance to anti-angiogenic therapy. Nat Med 19 (2013), 1114–1123.
40. Church, S.E., Galon, J., Tumor microenvironment and immunotherapy: the whole picture is better than a glimpse. Immunity 43 (2015), 631–633.
41. Clayton, A., Tabi, Z., Exosomes and the MICA-NKG2D system in cancer. Blood Cells Mol Dis 34 (2005), 206–213.
42. Coffelt, S.B., Kersten, K., Doornebal, C.W., Weiden, J., Vrijland, K., Hau, C.S.,.. de Visser, K.E., IL-17-producing gammadelta T cells and neutrophils conspire to promote breast cancer metastasis. Nature 522 (2015), 345–348.
43. Coffelt, S.B., Wellenstein, M.D., de Visser, K.E., Neutrophils in cancer: neutral no more. Nat Rev Cancer 16 (2016), 431–446.
44. Condamine, T., Dominguez, G.A., Youn, J.-I., Kossenkov, A.V., Mony, S., Alicea-Torres, K.,.. Gabrilovich, D.I., Lectin-type oxidized LDL receptor-1 distinguishes population of human polymorphonuclear myeloid-derived suppressor cells in cancer patients. Sci Immunol, 1, 2016.
45. Cools-Lartigue, J., Spicer, J., McDonald, B., Gowing, S., Chow, S., Giannias, B.,.. Ferri, L., Neutrophil extracellular traps sequester circulating tumor cells and promote metastasis. J Clin Invest 123 (2013), 3446–3458.
46. Coppe, J.P., Desprez, P.Y., Krtolica, A., Campisi, J., The senescence-associated secretory phenotype: the dark side of tumor suppression. Annu Rev Pathol 5 (2010), 99–118.
47. Crende, O., Sabatino, M., Valcarcel, M., Carrascal, T., Riestra, P., Lopez-Guerrero, J.A.,.. Vidal-Vanaclocha, F., Metastatic lesions with and without interleukin-18-dependent genes in advanced-stage melanoma patients. Am J Pathol 183 (2013), 69–82.
48. Dagenais, M., Saleh, M., Linking cancer-induced Nlrp3 inflammasome activation to efficient NK cell-mediated immunosurveillance. Oncoimmunology, 5, 2016, e1129484.
49. Dang, E.V., Barbi, J., Yang, H.Y., Jinasena, D., Yu, H., Zheng, Y.,.. Pan, F., Control of T(H)17/T(reg) balance by hypoxia-inducible factor 1. Cell 146 (2011), 772–784.
50. Demory Beckler, M., Higginbotham, J.N., Franklin, J.L., Ham, A.J., Halvey, P.J., Imasuen, I.E.,.. Coffey, R.J., Proteomic analysis of exosomes from mutant KRAS colon cancer cells identifies intercellular transfer of mutant KRAS. Mol Cell Proteomics 12 (2013), 343–355.
51. Deng, B., Zhu, J.M., Wang, Y., Liu, T.T., Ding, Y.B., Xiao, W.M.,.. Shen, X.Z., Intratumor hypoxia promotes immune tolerance by inducing regulatory T cells via TGF-beta1 in gastric cancer. PLoS One, 8, 2013, e63777.
52. Dhawan, P., Richmond, A., Role of CXCL1 in tumorigenesis of melanoma. J Leukoc Biol 72 (2002), 9–18.
53. Dinarello, C.A., Biologic basis for interleukin-1 in disease. Blood 87 (1996), 2095–2147.
54. Dostert, C., Petrilli, V., Van Bruggen, R., Steele, C., Mossman, B.T., Tschopp, J., Innate immune activation through Nalp3 inflammasome sensing of asbestos and silica. Science 320 (2008), 674–677.
55. Dranoff, G., Cytokines in cancer pathogenesis and cancer therapy. Nat Rev Cancer 4 (2004), 11–22.
56. Drutskaya, M.S., Efimov, G.A., Kruglov, A.A., Kuprash, D.V., Nedospasov, S.A., Tumor necrosis factor, lymphotoxin and cancer. IUBMB Life 62 (2010), 283–289.
57. Du, P., Liu, Y., Ren, H., Zhao, J., Zhang, X., Patel, R.,.. Huang, G., Expression of chemokine receptor CCR7 is a negative prognostic factor for patients with gastric cancer: a meta-analysis. Gastric Cancer, 2016, 10.1007/s10120-016-0602-8.
58. Du, R., Lu, K.V., Petritsch, C., Liu, P., Ganss, R., Passegue, E.,.. Bergers, G., HIF1alpha induces the recruitment of bone marrow-derived vascular modulatory cells to regulate tumor angiogenesis and invasion. Cancer Cell 13 (2008), 206–220.
59. Dursun, B., He, Z., Somerset, H., Oh, D.J., Faubel, S., Edelstein, C.L., Caspases and calpain are independent mediators of cisplatin-induced endothelial cell necrosis. Am J Physiol Renal Physiol 291 (2006), F578–F587.
60. Ehrchen, J.M., Sunderkotter, C., Foell, D., Vogl, T., Roth, J., The endogenous Toll-like receptor 4 agonist S100A8/S100A9 (calprotectin) as innate amplifier of infection, autoimmunity, and cancer. J Leukoc Biol 86 (2009), 557–566.
61. Elaraj, D.M., Weinreich, D.M., Varghese, S., Puhlmann, M., Hewitt, S.M., Carroll, N.M.,.. Alexander, H.R., The role of interleukin 1 in growth and metastasis of human cancer xenografts. Clin Cancer Res 12 (2006), 1088–1096.
62. Erdman, S.E., Poutahidis, T., The microbiome modulates the tumor macroenvironment. Oncoimmunology, 3, 2014, e28271.
63. Erreni, M., Mantovani, A., Allavena, P., Tumor-associated macrophages (TAM) and inflammation in colorectal cancer. Cancer Microenviron 4 (2011), 141–154.
64. Eruslanov, E.B., Bhojnagarwala, P.S., Quatromoni, J.G., Stephen, T.L., Ranganathan, A., Deshpande, C.,.. Singhal, S., Tumor-associated neutrophils stimulate T cell responses in early-stage human lung cancer. J Clin Invest 124 (2014), 5466–5480.
65. Fabbi, M., Carbotti, G., Ferrini, S., Context-dependent role of IL-18 in cancer biology and counter-regulation by IL-18BP. J Leukoc Biol 97 (2015), 665–675.
66. Fabbri, M., Paone, A., Calore, F., Galli, R., Gaudio, E., Santhanam, R.,.. Croce, C.M., MicroRNAs bind to Toll-like receptors to induce prometastatic inflammatory response. Proc Natl Acad Sci U S A 109 (2012), E2110–E2116.
67. Forster, R., Davalos-Misslitz, A.C., Rot, A., CCR7 and its ligands: balancing immunity and tolerance. Nat Rev Immunol 8 (2008), 362–371.
68. Francia di Celle, P., Mariani, S., Riera, L., Stacchini, A., Reato, G., Foa, R., Interleukin-8 induces the accumulation of B-cell chronic lymphocytic leukemia cells by prolonging survival in an autocrine fashion. Blood 87 (1996), 4382–4389.
69. Fucikova, J., Kralikova, P., Fialova, A., Brtnicky, T., Rob, L., Bartunkova, J., Spisek, R., Human tumor cells killed by anthracyclines induce a tumor-specific immune response. Cancer Res 71 (2011), 4821–4833.
70. Gabrilovich, D.I., Ostrand-Rosenberg, S., Bronte, V., Coordinated regulation of myeloid cells by tumours. Nat Rev Immunol 12 (2012), 253–268.
71. Garg, A.D., Krysko, D.V., Verfaillie, T., Kaczmarek, A., Ferreira, G.B., Marysael, T.,.. Agostinis, P., A novel pathway combining calreticulin exposure and ATP secretion in immunogenic cancer cell death. EMBO J 31 (2012), 1062–1079.
72. Gilchrist, A., Gauntner, T.D., Fazzini, A., Alley, K.M., Pyen, D.S., Ahn, J.,.. Merritt, J.R., Identifying bias in CCR1 antagonists using radiolabelled binding, receptor internalization, beta-arrestin translocation and chemotaxis assays. Br J Pharmacol 171 (2014), 5127–5138.
73. Ginestier, C., Liu, S., Diebel, M.E., Korkaya, H., Luo, M., Brown, M.,.. Wicha, M.S., CXCR1 blockade selectively targets human breast cancer stem cells in vitro and in xenografts. J Clin Invest 120 (2010), 485–497.
74. Goswami, S., Sahai, E., Wyckoff, J.B., Cammer, M., Cox, D., Pixley, F.J.,.. Condeelis, J.S., Macrophages promote the invasion of breast carcinoma cells via a colony-stimulating factor-1/epidermal growth factor paracrine loop. Cancer Res 65 (2005), 5278–5283.
75. Grivennikov, S.I., Greten, F.R., Karin, M., Immunity, inflammation, and cancer. Cell 140 (2010), 883–899.
76. Grivennikov, S.I., Karin, M., Inflammatory cytokines in cancer: tumour necrosis factor and interleukin 6 take the stage. Ann Rheum Dis 70:Suppl. 1 (2011), i104–i108.
77. Grivennikov, S.I., Wang, K., Mucida, D., Stewart, C.A., Schnabl, B., Jauch, D.,.. Karin, M., Adenoma-linked barrier defects and microbial products drive IL-23/IL-17-mediated tumour growth. Nature 491 (2012), 254–258.
78. Gross, J.C., Boutros, M., Secretion and extracellular space travel of Wnt proteins. Curr Opin Genet Dev 23 (2013), 385–390.
79. Gross, J.C., Chaudhary, V., Bartscherer, K., Boutros, M., Active Wnt proteins are secreted on exosomes. Nat Cell Biol 14 (2012), 1036–1045.
80. Gu, Q., He, Y., Ji, J., Yao, Y., Shen, W., Luo, J.,.. Ding, W.Q., Hypoxia-inducible factor 1alpha (HIF-1alpha) and reactive oxygen species (ROS) mediates radiation-induced invasiveness through the SDF-1alpha/CXCR4 pathway in non-small cell lung carcinoma cells. Oncotarget 6 (2015), 10893–10907.
81. Guadagni, F., Ferroni, P., Palmirotta, R., Portarena, I., Formica, V., Roselli, M., Review. TNF/VEGF cross-talk in chronic inflammation-related cancer initiation and progression: an early target in anticancer therapeutic strategy. In Vivo 21 (2007), 147–161.
82. Gunel, N., Coskun, U., Sancak, B., Hasdemir, O., Sare, M., Bayram, O.,.. Ozkan, S., Prognostic value of serum IL-18 and nitric oxide activity in breast cancer patients at operable stage. Am J Clin Oncol 26 (2003), 416–421.
83. Hanahan, D., Weinberg, R.A., Hallmarks of cancer: the next generation. Cell 144 (2011), 646–674.
84. Hedlund, M., Nagaeva, O., Kargl, D., Baranov, V., Mincheva-Nilsson, L., Thermal- and oxidative stress causes enhanced release of NKG2D ligand-bearing immunosuppressive exosomes in leukemia/lymphoma T and B cells. PLoS One, 6, 2011, e16899.
85. Hinrichs, C.S., Kaiser, A., Paulos, C.M., Cassard, L., Sanchez-Perez, L., Heemskerk, B.,.. Restifo, N.P., Type 17 CD8 + T cells display enhanced antitumor immunity. Blood 114 (2009), 596–599.
86. Hoechst, B., Voigtlaender, T., Ormandy, L., Gamrekelashvili, J., Zhao, F., Wedemeyer, H.,.. Korangy, F., Myeloid derived suppressor cells inhibit natural killer cells in patients with hepatocellular carcinoma via the NKp30 receptor. Hepatology 50 (2009), 799–807.
87. Hong, B.S., Cho, J.H., Kim, H., Choi, E.J., Rho, S., Kim, J.,.. Gho, Y.S., Colorectal cancer cell-derived microvesicles are enriched in cell cycle-related mRNAs that promote proliferation of endothelial cells. BMC Genomics, 10, 2009, 556.
88. Hood, J.L., Pan, H., Lanza, G.M., Wickline, S.A., Consortium for Translational Research in Advanced, I., & Nanomedicine, Paracrine induction of endothelium by tumor exosomes. Lab Invest 89 (2009), 1317–1328.
89. Hoshino, A., Costa-Silva, B., Shen, T.L., Rodrigues, G., Hashimoto, A., Tesic Mark, M.,.. Lyden, D., Tumour exosome integrins determine organotropic metastasis. Nature 527 (2015), 329–335.
90. Houghton, A.M., Quintero, P.A., Perkins, D.L., Kobayashi, D.K., Kelley, D.G., Marconcini, L.A.,.. Shapiro, S.D., Elastin fragments drive disease progression in a murine model of emphysema. J Clin Invest 116 (2006), 753–759.
91. Huang, F.Y., Chan, A.O., Rashid, A., Wong, D.K., Seto, W.K., Cho, C.H.,.. Yuen, M.F., Interleukin-1beta increases the risk of gastric cancer through induction of aberrant DNA methylation in a mouse model. Oncol Lett 11 (2016), 2919–2924.
92. Huang, Q., Li, F., Liu, X., Li, W., Shi, W., Liu, F.F.,.. Li, C.Y., Caspase 3-mediated stimulation of tumor cell repopulation during cancer radiotherapy. Nat Med 17 (2011), 860–866.
93. Huang, S., Mills, L., Mian, B., Tellez, C., McCarty, M., Yang, X.D.,.. Bar-Eli, M., Fully humanized neutralizing antibodies to interleukin-8 (ABX-IL8) inhibit angiogenesis, tumor growth, and metastasis of human melanoma. Am J Pathol 161 (2002), 125–134.
94. Huber, V., Fais, S., Iero, M., Lugini, L., Canese, P., Squarcina, P.,.. Rivoltini, L., Human colorectal cancer cells induce T-cell death through release of proapoptotic microvesicles: role in immune escape. Gastroenterology 128 (2005), 1796–1804.
95. Iida, N., Dzutsev, A., Stewart, C.A., Smith, L., Bouladoux, N., Weingarten, R.A.,.. Goldszmid, R.S., Commensal bacteria control cancer response to therapy by modulating the tumor microenvironment. Science 342 (2013), 967–970.
96. Imtiyaz, H.Z., Williams, E.P., Hickey, M.M., Patel, S.A., Durham, A.C., Yuan, L.J.,.. Simon, M.C., Hypoxia-inducible factor 2alpha regulates macrophage function in mouse models of acute and tumor inflammation. J Clin Invest 120 (2010), 2699–2714.
97. Ishii, T., Ishida, T., Utsunomiya, A., Inagaki, A., Yano, H., Komatsu, H.,.. Ueda, R., Defucosylated humanized anti-CCR4 monoclonal antibody KW-0761 as a novel immunotherapeutic agent for adult T-cell leukemia/lymphoma. Clin Cancer Res 16 (2010), 1520–1531.
98. Josefowicz, S.Z., Lu, L.F., Rudensky, A.Y., Regulatory T cells: mechanisms of differentiation and function. Annu Rev Immunol 30 (2012), 531–564.
99. Karavitis, J., Hix, L.M., Shi, Y.H., Schultz, R.F., Khazaie, K., Zhang, M., Regulation of COX2 expression in mouse mammary tumor cells controls bone metastasis and PGE2-induction of regulatory T cell migration. PLoS One, 7, 2012, e46342.
100. Kasper, M., Jaks, V., Are, A., Bergstrom, A., Schwager, A., Svard, J.,.. Toftgard, R., Wounding enhances epidermal tumorigenesis by recruiting hair follicle keratinocytes. Proc Natl Acad Sci U S A 108 (2011), 4099–4104.
101. Kawano, M., Hirano, T., Matsuda, T., Taga, T., Horii, Y., Iwato, K., Asaoku, H., Tang, B., Tanabe, O., Tanaka, H., et al. Autocrine generation and requirement of BSF-2/IL-6 for human multiple myelomas. Nature 332 (1988), 83–85.
102. Kim, J.W., Wieckowski, E., Taylor, D.D., Reichert, T.E., Watkins, S., Whiteside, T.L., Fas ligand-positive membranous vesicles isolated from sera of patients with oral cancer induce apoptosis of activated T lymphocytes. Clin Cancer Res 11 (2005), 1010–1020.
103. Kitamura, T., Kometani, K., Hashida, H., Matsunaga, A., Miyoshi, H., Hosogi, H.,.. Taketo, M.M., SMAD4-deficient intestinal tumors recruit CCR1 + myeloid cells that promote invasion. Nat Genet 39 (2007), 467–475.
104. Klein, A., Schwartz, H., Sagi-Assif, O., Meshel, T., Izraely, S., Ben Menachem, S.,.. Erez, N., Astrocytes facilitate melanoma brain metastasis via secretion of IL-23. J Pathol 236 (2015), 116–127.
105. Klinker, M.W., Lizzio, V., Reed, T.J., Fox, D.A., Lundy, S.K., Human B cell-derived lymphoblastoid cell lines constitutively produce fas ligand and secrete MHCII(+)FasL(+) killer exosomes. Front Immunol, 5, 2014, 144.
106. Koelink, P.J., Overbeek, S.A., Braber, S., de Kruijf, P., Folkerts, G., Smit, M.J., Kraneveld, A.D., Targeting chemokine receptors in chronic inflammatory diseases: an extensive review. Pharmacol Ther 133 (2012), 1–18.
107. Komarova, E.A., Krivokrysenko, V., Wang, K., Neznanov, N., Chernov, M.V., Komarov, P.G.,.. Gudkov, A.V., p53 is a suppressor of inflammatory response in mice. FASEB J 19 (2005), 1030–1032.
108. Korkaya, H., Kim, G.I., Davis, A., Malik, F., Henry, N.L., Ithimakin, S.,.. Wicha, M.S., Activation of an IL6 inflammatory loop mediates trastuzumab resistance in HER2 + breast cancer by expanding the cancer stem cell population. Mol Cell 47 (2012), 570–584.
109. Krysko, D.V., Garg, A.D., Kaczmarek, A., Krysko, O., Agostinis, P., Vandenabeele, P., Immunogenic cell death and DAMPs in cancer therapy. Nat Rev Cancer 12 (2012), 860–875.
110. Kuang, D.M., Zhao, Q., Peng, C., Xu, J., Zhang, J.P., Wu, C., Zheng, L., Activated monocytes in peritumoral stroma of hepatocellular carcinoma foster immune privilege and disease progression through PD-L1. J Exp Med 206 (2009), 1327–1337.
111. Kulbe, H., Hagemann, T., Szlosarek, P.W., Balkwill, F.R., Wilson, J.L., The inflammatory cytokine tumor necrosis factor-alpha regulates chemokine receptor expression on ovarian cancer cells. Cancer Res 65 (2005), 10355–10362.
112. Kulbe, H., Thompson, R., Wilson, J.L., Robinson, S., Hagemann, T., Fatah, R.,.. Balkwill, F., The inflammatory cytokine tumor necrosis factor-alpha generates an autocrine tumor-promoting network in epithelial ovarian cancer cells. Cancer Res 67 (2007), 585–592.
113. Kumar, V., Cheng, P., Condamine, T., Mony, S., Languino, L.R., McCaffrey, J.C.,.. Gabrilovich, D.I., CD45 phosphatase inhibits STAT3 transcription factor activity in myeloid cells and promotes tumor-associated macrophage differentiation. Immunity 44 (2016), 303–315.
114. Kuraishy, A., Karin, M., Grivennikov, S.I., Tumor promotion via injury- and death-induced inflammation. Immunity 35 (2011), 467–477.
115. Lai, T., Wang, K., Hou, Q., Zhang, J., Yuan, J., Yuan, L.,.. Xi, M., Interleukin 17 induces up-regulation of chemokine and cytokine expression via activation of the nuclear factor kappaB and extracellular signal-regulated kinase 1/2 pathways in gynecologic cancer cell lines. Int J Gynecol Cancer 21 (2011), 1533–1539.
116. Landsberg, J., Kohlmeyer, J., Renn, M., Bald, T., Rogava, M., Cron, M.,.. Tuting, T., Melanomas resist T-cell therapy through inflammation-induced reversible dedifferentiation. Nature 490 (2012), 412–416.
117. Lasry, A., Zinger, A., Ben-Neriah, Y., Inflammatory networks underlying colorectal cancer. Nat Immunol 17 (2016), 230–240.
118. Lee, J.W., Shahzad, M.M., Lin, Y.G., Armaiz-Pena, G., Mangala, L.S., Han, H.D.,.. Sood, A.K., Surgical stress promotes tumor growth in ovarian carcinoma. Clin Cancer Res 15 (2009), 2695–2702.
119. Lee, M.J., Lee, J.K., Choi, J.W., Lee, C.S., Sim, J.H., Cho, C.H.,.. Ye, S.K., Interleukin-6 induces S100A9 expression in colonic epithelial cells through STAT3 activation in experimental ulcerative colitis. PLoS One, 7, 2012, e38801.
120. Lee, Y.J., Kim, D.H., Lee, S.H., Nam, H.S., Roh, M.R., Cho, M.K., Chemokine receptor CCR3 expression in malignant cutaneous tumors. Ann Dermatol 22 (2010), 412–417.
121. Lerman, O.Z., Greives, M.R., Singh, S.P., Thanik, V.D., Chang, C.C., Seiser, N.,.. Levine, J.P., Low-dose radiation augments vasculogenesis signaling through HIF-1-dependent and -independent SDF-1 induction. Blood 116 (2010), 3669–3676.
122. Lesina, M., Kurkowski, M.U., Ludes, K., Rose-John, S., Treiber, M., Kloppel, G.,.. Algul, H., Stat3/Socs3 activation by IL-6 transsignaling promotes progression of pancreatic intraepithelial neoplasia and development of pancreatic cancer. Cancer Cell 19 (2011), 456–469.
123. Lewis, A.M., Varghese, S., Xu, H., Alexander, H.R., Interleukin-1 and cancer progression: the emerging role of interleukin-1 receptor antagonist as a novel therapeutic agent in cancer treatment. J Transl Med, 4, 2006, 48.
124. Li, A., Varney, M.L., Singh, R.K., Constitutive expression of growth regulated oncogene (gro) in human colon carcinoma cells with different metastatic potential and its role in regulating their metastatic phenotype. Clin Exp Metastasis 21 (2004), 571–579.
125. Li, A., Varney, M.L., Valasek, J., Godfrey, M., Dave, B.J., Singh, R.K., Autocrine role of interleukin-8 in induction of endothelial cell proliferation, survival, migration and MMP-2 production and angiogenesis. Angiogenesis 8 (2005), 63–71.
126. Li, H., Han, Y., Guo, Q., Zhang, M., Cao, X., Cancer-expanded myeloid-derived suppressor cells induce anergy of NK cells through membrane-bound TGF-beta 1. J Immunol 182 (2009), 240–249.
127. Li, J., Zhang, L., Zhang, J., Wei, Y., Li, K., Huang, L.,.. Lin, P., Interleukin 23 regulates proliferation of lung cancer cells in a concentration-dependent way in association with the interleukin-23 receptor. Carcinogenesis 34 (2013), 658–666.
128. Li, Q., Han, Y., Fei, G., Guo, Z., Ren, T., Liu, Z., IL-17 promoted metastasis of non-small-cell lung cancer cells. Immunol Lett 148 (2012), 144–150.
129. Li, X., Wang, S., Zhu, R., Li, H., Han, Q., Zhao, R.C., Lung tumor exosomes induce a pro-inflammatory phenotype in mesenchymal stem cells via NFkappaB-TLR signaling pathway. J Hematol Oncol, 9, 2016, 42.
130. Lim, H.X., Hong, H.J., Cho, D., Kim, T.S., IL-18 enhances immunosuppressive responses by promoting differentiation into monocytic myeloid-derived suppressor cells. J Immunol 193 (2014), 5453–5460.
131. Lim, S.Y., Yuzhalin, A.E., Gordon-Weeks, A.N., Muschel, R.J., Targeting the CCL2-CCR2 signaling axis in cancer metastasis. Oncotarget 7 (2016), 28697–28710.
132. Lin, S., Wan, S., Sun, L., Hu, J., Fang, D., Zhao, R.,.. Zhang, L., Chemokine C-C motif receptor 5 and C-C motif ligand 5 promote cancer cell migration under hypoxia. Cancer Sci 103 (2012), 904–912.
133. Lippitz, B.E., Cytokine patterns in patients with cancer: a systematic review. Lancet Oncol 14 (2013), e218–e228.
134. Lust, J.A., Lacy, M.Q., Zeldenrust, S.R., Dispenzieri, A., Gertz, M.A., Witzig, T.E.,.. Donovan, K.A., Induction of a chronic disease state in patients with smoldering or indolent multiple myeloma by targeting interleukin 1β-induced interleukin 6 production and the myeloma proliferative component. Mayo Clin Proc 84 (2009), 114–122.
135. Lv, M., Xu, Y., Tang, R., Ren, J., Shen, S., Chen, Y.,.. Wang, T., miR141-CXCL1-CXCR2 signaling-induced Treg recruitment regulates metastases and survival of non-small cell lung cancer. Mol Cancer Ther 13 (2014), 3152–3162.
136. Mahoney, K.M., Rennert, P.D., Freeman, G.J., Combination cancer immunotherapy and new immunomodulatory targets. Nat Rev Drug Discov 14 (2015), 561–584.
137. Majima, T., Ichikura, T., Chochi, K., Kawabata, T., Tsujimoto, H., Sugasawa, H.,.. Mochizuki, H., Exploitation of interleukin-18 by gastric cancers for their growth and evasion of host immunity. Int J Cancer 118 (2006), 388–395.
138. Mantovani, A., Allavena, P., Sica, A., Balkwill, F., Cancer-related inflammation. Nature 454 (2008), 436–444.
139. Marvel, D., Gabrilovich, D.I., Myeloid-derived suppressor cells in the tumor microenvironment: expect the unexpected. J Clin Invest 125 (2015), 3356–3364.
140. Mazzoni, A., Bronte, V., Visintin, A., Spitzer, J.H., Apolloni, E., Serafini, P.,.. Segal, D.M., Myeloid suppressor lines inhibit T cell responses by an NO-dependent mechanism. J Immunol 168 (2002), 689–695.
141. McCready, J., Sims, J.D., Chan, D., Jay, D.G., Secretion of extracellular hsp90alpha via exosomes increases cancer cell motility: a role for plasminogen activation. BMC Cancer, 10, 2010, 294.
142. McGeachy, M.J., Bak-Jensen, K.S., Chen, Y., Tato, C.M., Blumenschein, W., McClanahan, T., Cua, D.J., TGF-beta and IL-6 drive the production of IL-17 and IL-10 by T cells and restrain T(H)-17 cell-mediated pathology. Nat Immunol 8 (2007), 1390–1397.
143. McLoed, A.G., Sherrill, T.P., Cheng, D.S., Han, W., Saxon, J.A., Gleaves, L.A.,.. Blackwell, T.S., Neutrophil-derived IL-1beta impairs the efficacy of NF-kappaB inhibitors against lung cancer. Cell Rep 16 (2016), 120–132.
144. Mei, Z., Chen, S., Chen, C., Xiao, B., Li, F., Wang, Y., Tao, Z., Interleukin-23 facilitates thyroid cancer cell migration and invasion by inhibiting SOCS4 expression via microRNA-25. PLoS One, 10, 2015, e0139456.
145. Melo, S.A., Sugimoto, H., O'Connell, J.T., Kato, N., Villanueva, A., Vidal, A.,.. Kalluri, R., Cancer exosomes perform cell-independent microRNA biogenesis and promote tumorigenesis. Cancer Cell 26 (2014), 707–721.
146. Mencarelli, A., Graziosi, L., Renga, B., Cipriani, S., D'Amore, C., Francisci, D.,.. Fiorucci, S., CCR5 antagonism by maraviroc reduces the potential for gastric cancer cell dissemination. Transl Oncol 6 (2013), 784–793.
147. Miki, S., Iwano, M., Miki, Y., Yamamoto, M., Tang, B., Yokokawa, K.,.. Kishimoto, T., Interleukin-6 (IL-6) functions as an in vitro autocrine growth factor in renal cell carcinomas. FEBS Lett 250 (1989), 607–610.
148. Moisan, F., Francisco, E.B., Brozovic, A., Duran, G.E., Wang, Y.C., Chaturvedi, S.,.. Sikic, B.I., Enhancement of paclitaxel and carboplatin therapies by CCL2 blockade in ovarian cancers. Mol Oncol 8 (2014), 1231–1239.
149. Moore, R.J., Owens, D.M., Stamp, G., Arnott, C., Burke, F., East, N.,.. Balkwill, F., Mice deficient in tumor necrosis factor-alpha are resistant to skin carcinogenesis. Nat Med 5 (1999), 828–831.
150. Murakami, T., Cardones, A.R., Finkelstein, S.E., Restifo, N.P., Klaunberg, B.A., Nestle, F.O.,.. Hwang, S.T., Immune evasion by murine melanoma mediated through CC chemokine receptor-10. J Exp Med 198 (2003), 1337–1347.
151. Muranski, P., Boni, A., Antony, P.A., Cassard, L., Irvine, K.R., Kaiser, A.,.. Restifo, N.P., Tumor-specific Th17-polarized cells eradicate large established melanoma. Blood 112 (2008), 362–373.
152. Murooka, T.T., Rahbar, R., Fish, E.N., CCL5 promotes proliferation of MCF-7 cells through mTOR-dependent mRNA translation. Biochem Biophys Res Commun 387 (2009), 381–386.
153. Murugaiyan, G., Saha, B., Protumor vs antitumor functions of IL-17. J Immunol 183 (2009), 4169–4175.
154. Nakahara, H., Song, J., Sugimoto, M., Hagihara, K., Kishimoto, T., Yoshizaki, K., Nishimoto, N., Anti-interleukin-6 receptor antibody therapy reduces vascular endothelial growth factor production in rheumatoid arthritis. Arthritis Rheum 48 (2003), 1521–1529.
155. Nazarenko, I., Marhaba, R., Reich, E., Voronov, E., Vitacolonna, M., Hildebrand, D.,.. Zoller, M., Tumorigenicity of IL-1alpha- and IL-1beta-deficient fibrosarcoma cells. Neoplasia 10 (2008), 549–562.
156. Neurath, M.F., Finotto, S., IL-6 signaling in autoimmunity, chronic inflammation and inflammation-associated cancer. Cytokine Growth Factor Rev 22 (2011), 83–89.
157. Novitskiy, S.V., Pickup, M.W., Gorska, A.E., Owens, P., Chytil, A., Aakre, M.,.. Moses, H.L., TGF-beta receptor II loss promotes mammary carcinoma progression by Th17 dependent mechanisms. Cancer Discov 1 (2011), 430–441.
158. Numasaki, M., Fukushi, J., Ono, M., Narula, S.K., Zavodny, P.J., Kudo, T.,.. Lotze, M.T., Interleukin-17 promotes angiogenesis and tumor growth. Blood 101 (2003), 2620–2627.
159. O'Shea, J.J., Ma, A., Lipsky, P., Cytokines and autoimmunity. Nat Rev Immunol 2 (2002), 37–45.
160. Obeid, M., Tesniere, A., Ghiringhelli, F., Fimia, G.M., Apetoh, L., Perfettini, J.L.,.. Kroemer, G., Calreticulin exposure dictates the immunogenicity of cancer cell death. Nat Med 13 (2007), 54–61.
161. Okamura, H., Tsutsui, H., Kashiwamura, S., Yoshimoto, T., Nakanishi, K., Interleukin-18: a novel cytokine that augments both innate and acquired immunity. Adv Immunol 70 (1998), 281–312.
162. Olkhanud, P.B., Baatar, D., Bodogai, M., Hakim, F., Gress, R., Anderson, R.L.,.. Biragyn, A., Breast cancer lung metastasis requires expression of chemokine receptor CCR4 and regulatory T cells. Cancer Res 69 (2009), 5996–6004.
163. Onnis, B., Fer, N., Rapisarda, A., Perez, V.S., Melillo, G., Autocrine production of IL-11 mediates tumorigenicity in hypoxic cancer cells. J Clin Invest 123 (2013), 1615–1629.
164. Orengo, A.M., Fabbi, M., Miglietta, L., Andreani, C., Bruzzone, M., Puppo, A.,.. Ferrini, S., Interleukin (IL)-18, a biomarker of human ovarian carcinoma, is predominantly released as biologically inactive precursor. Int J Cancer 129 (2011), 1116–1125.
165. Ostrand-Rosenberg, S., Sinha, P., Myeloid-derived suppressor cells: linking inflammation and cancer. J Immunol 182 (2009), 4499–4506.
166. Palazon, A., Goldrath, A.W., Nizet, V., Johnson, R.S., HIF transcription factors, inflammation, and immunity. Immunity 41 (2014), 518–528.
167. Pan, B., Shen, J., Cao, J., Zhou, Y., Shang, L., Jin, S.,.. Yu, Y., Interleukin-17 promotes angiogenesis by stimulating VEGF production of cancer cells via the STAT3/GIV signaling pathway in non-small-cell lung cancer. Sci Rep, 5, 2015, 16053.
168. Pan, P.Y., Ma, G., Weber, K.J., Ozao-Choy, J., Wang, G., Yin, B.,.. Chen, S.H., Immune stimulatory receptor CD40 is required for T-cell suppression and T regulatory cell activation mediated by myeloid-derived suppressor cells in cancer. Cancer Res 70 (2010), 99–108.
169. Parker, K.H., Beury, D.W., Ostrand-Rosenberg, S., Myeloid-derived suppressor cells: critical cells driving immune suppression in the tumor microenvironment. Adv Cancer Res 128 (2015), 95–139.
170. Peng, P., Yan, Y., Keng, S., Exosomes in the ascites of ovarian cancer patients: origin and effects on anti-tumor immunity. Oncol Rep 25 (2011), 749–762.
171. Pienta, K.J., Machiels, J.P., Schrijvers, D., Alekseev, B., Shkolnik, M., Crabb, S.J.,.. de Bono, J.S., Phase 2 study of carlumab (CNTO 888), a human monoclonal antibody against CC-chemokine ligand 2 (CCL2), in metastatic castration-resistant prostate cancer. Invest New Drugs 31 (2013), 760–768.
172. Pikarsky, E., Porat, R.M., Stein, I., Abramovitch, R., Amit, S., Kasem, S.,.. Ben-Neriah, Y., NF-kappaB functions as a tumour promoter in inflammation-associated cancer. Nature 431 (2004), 461–466.
173. Popivanova, B.K., Kitamura, K., Wu, Y., Kondo, T., Kagaya, T., Kaneko, S.,.. Mukaida, N., Blocking TNF-alpha in mice reduces colorectal carcinogenesis associated with chronic colitis. J Clin Invest 118 (2008), 560–570.
174. Pribluda, A., Elyada, E., Wiener, Z., Hamza, H., Goldstein, R.E., Biton, M.,.. Ben-Neriah, Y., A senescence-inflammatory switch from cancer-inhibitory to cancer-promoting mechanism. Cancer Cell 24 (2013), 242–256.
175. Puthier, D., Derenne, S., Barille, S., Moreau, P., Harousseau, J.L., Bataille, R., Amiot, M., Mcl-1 and Bcl-xL are co-regulated by IL-6 in human myeloma cells. Br J Haematol 107 (1999), 392–395.
176. Putoczki, T.L., Thiem, S., Loving, A., Busuttil, R.A., Wilson, N.J., Ziegler, P.K.,.. Ernst, M., Interleukin-11 is the dominant IL-6 family cytokine during gastrointestinal tumorigenesis and can be targeted therapeutically. Cancer Cell 24 (2013), 257–271.
177. Pylayeva-Gupta, Y., Lee, K.E., Hajdu, C.H., Miller, G., Bar-Sagi, D., Oncogenic Kras-induced GM-CSF production promotes the development of pancreatic neoplasia. Cancer Cell 21 (2012), 836–847.
178. Qian, B.Z., Li, J., Zhang, H., Kitamura, T., Zhang, J., Campion, L.R.,.. Pollard, J.W., CCL2 recruits inflammatory monocytes to facilitate breast-tumour metastasis. Nature 475 (2011), 222–225.
179. Qian, X., Gu, L., Ning, H., Zhang, Y., Hsueh, E.C., Fu, M.,.. Liu, J., Increased Th17 cells in the tumor microenvironment is mediated by IL-23 via tumor-secreted prostaglandin E2. J Immunol 190 (2013), 5894–5902.
180. Qin, Y., Ekmekcioglu, S., Liu, P., Duncan, L.M., Lizee, G., Poindexter, N., Grimm, E.A., Constitutive aberrant endogenous interleukin-1 facilitates inflammation and growth in human melanoma. Mol Cancer Res 9 (2011), 1537–1550.
181. Qu, J.L., Qu, X.J., Zhao, M.F., Teng, Y.E., Zhang, Y., Hou, K.Z.,.. Liu, Y.P., Gastric cancer exosomes promote tumour cell proliferation through PI3K/Akt and MAPK/ERK activation. Dig Liver Dis 41 (2009), 875–880.
182. Rakoff-Nahoum, S., Medzhitov, R., Toll-like receptors and cancer. Nat Rev Cancer 9 (2009), 57–63.
183. Ramteke, A., Ting, H., Agarwal, C., Mateen, S., Somasagara, R., Hussain, A.,.. Deep, G., Exosomes secreted under hypoxia enhance invasiveness and stemness of prostate cancer cells by targeting adherens junction molecules. Mol Carcinog 54 (2015), 554–565.
184. Ren, L., Wang, X., Dong, Z., Liu, J., Zhang, S., Bone metastasis from breast cancer involves elevated IL-11 expression and the gp130/STAT3 pathway. Med Oncol, 30, 2013, 634.
185. Roca, H., Varsos, Z.S., Sud, S., Craig, M.J., Ying, C., Pienta, K.J., CCL2 and interleukin-6 promote survival of human CD11b + peripheral blood mononuclear cells and induce M2-type macrophage polarization. J Biol Chem 284 (2009), 34342–34354.
186. Rodriguez, P.C., Quiceno, D.G., Ochoa, A.C., L-arginine availability regulates T-lymphocyte cell-cycle progression. Blood 109 (2007), 1568–1573.
187. Sakaguchi, S., Yamaguchi, T., Nomura, T., Ono, M., Regulatory T cells and immune tolerance. Cell 133 (2008), 775–787.
188. Sakuishi, K., Jayaraman, P., Behar, S.M., Anderson, A.C., Kuchroo, V.K., Emerging Tim-3 functions in antimicrobial and tumor immunity. Trends Immunol 32 (2011), 345–349.
189. Salama, P., Phillips, M., Grieu, F., Morris, M., Zeps, N., Joseph, D.,.. Iacopetta, B., Tumor-infiltrating FOXP3 + T regulatory cells show strong prognostic significance in colorectal cancer. J Clin Oncol 27 (2009), 186–192.
190. Santaolalla, R., Sussman, D.A., Ruiz, J.R., Davies, J.M., Pastorini, C., Espana, C.L.,.. Abreu, M.T., TLR4 activates the beta-catenin pathway to cause intestinal neoplasia. PLoS One, 8, 2013, e63298.
191. Sato, T., Takahashi, S., Mizumoto, T., Harao, M., Akizuki, M., Takasugi, M.,.. Yamashita, J., Neutrophil elastase and cancer. Surg Oncol 15 (2006), 217–222.
192. Sato, T., Terai, M., Tamura, Y., Alexeev, V., Mastrangelo, M.J., Selvan, S.R., Interleukin 10 in the tumor microenvironment: a target for anticancer immunotherapy. Immunol Res 51 (2011), 170–182.
193. Schaer, D.A., Hirschhorn-Cymerman, D., Wolchok, J.D., Targeting tumor-necrosis factor receptor pathways for tumor immunotherapy. J Immunother Cancer, 2, 2014, 7.
194. Schioppa, T., Uranchimeg, B., Saccani, A., Biswas, S.K., Doni, A., Rapisarda, A.,.. Sica, A., Regulation of the chemokine receptor CXCR4 by hypoxia. J Exp Med 198 (2003), 1391–1402.
195. Schmidt, A., Oberle, N., Weiss, E.M., Vobis, D., Frischbutter, S., Baumgrass, R.,.. Krammer, P.H., Human regulatory T cells rapidly suppress T cell receptor-induced Ca(2 +), NF-kappaB, and NFAT signaling in conventional T cells. Sci Signal, 4, 2011, ra90.
196. Schmielau, J., Finn, O.J., Activated granulocytes and granulocyte-derived hydrogen peroxide are the underlying mechanism of suppression of t-cell function in advanced cancer patients. Cancer Res 61 (2001), 4756–4760.
197. Schwitalla, S., Ziegler, P.K., Horst, D., Becker, V., Kerle, I., Begus-Nahrmann, Y.,.. Greten, F.R., Loss of p53 in enterocytes generates an inflammatory microenvironment enabling invasion and lymph node metastasis of carcinogen-induced colorectal tumors. Cancer Cell 23 (2013), 93–106.
198. Scotton, C.J., Wilson, J.L., Scott, K., Stamp, G., Wilbanks, G.D., Fricker, S.,.. Balkwill, F.R., Multiple actions of the chemokine CXCL12 on epithelial tumor cells in human ovarian cancer. Cancer Res 62 (2002), 5930–5938.
199. Semenza, G.L., Oxygen sensing, hypoxia-inducible factors, and disease pathophysiology. Annu Rev Pathol 9 (2014), 47–71.
200. Shchors, K., Shchors, E., Rostker, F., Lawlor, E.R., Brown-Swigart, L., Evan, G.I., The Myc-dependent angiogenic switch in tumors is mediated by interleukin 1beta. Genes Dev 20 (2006), 2527–2538.
201. Sheldon, H., Heikamp, E., Turley, H., Dragovic, R., Thomas, P., Oon, C.E.,.. Harris, A.L., New mechanism for Notch signaling to endothelium at a distance by Delta-like 4 incorporation into exosomes. Blood 116 (2010), 2385–2394.
202. Shengwei, H., Wenguang, X., Zhiyong, W., Xiaofeng, Q., Yufeng, W., Yanhong, N.,.. Wei, H., Crosstalk between the HIF-1 and toll-like receptor/nuclear factor-kappaB pathways in the oral squamous cell carcinoma microenvironment. Oncotarget 7 (2016), 37773–37789.
203. Shi, M., Chen, D., Yang, D., Liu, X.Y., CCL21-CCR7 promotes the lymph node metastasis of esophageal squamous cell carcinoma by up-regulating MUC1. J Exp Clin Cancer Res, 34, 2015, 149.
204. Singh, S., Singh, A.P., Sharma, B., Owen, L.B., Singh, R.K., CXCL8 and its cognate receptors in melanoma progression and metastasis. Future Oncol 6 (2010), 111–116.
205. Singhal, S., Bhojnagarwala, P.S., O'Brien, S., Moon, E.K., Garfall, A.L., Rao, A.S.,.. Eruslanov, E.B., Origin and role of a subset of tumor-associated neutrophils with antigen-presenting cell features in early-stage human lung cancer. Cancer Cell, 2016.
206. Sinha, P., Okoro, C., Foell, D., Freeze, H.H., Ostrand-Rosenberg, S., Srikrishna, G., Proinflammatory S100 proteins regulate the accumulation of myeloid-derived suppressor cells. J Immunol 181 (2008), 4666–4675.
207. Sivan, A., Corrales, L., Hubert, N., Williams, J.B., Aquino-Michaels, K., Earley, Z.M.,.. Gajewski, T.F., Commensal Bifidobacterium promotes antitumor immunity and facilitates anti-PD-L1 efficacy. Science 350 (2015), 1084–1089.
208. Smyth, M.J., Ngiow, S.F., Ribas, A., Teng, M.W., Combination cancer immunotherapies tailored to the tumour microenvironment. Nat Rev Clin Oncol 13 (2016), 143–158.
209. Sodir, N.M., Swigart, L.B., Karnezis, A.N., Hanahan, D., Evan, G.I., Soucek, L., Endogenous Myc maintains the tumor microenvironment. Genes Dev 25 (2011), 907–916.
210. Solinas, G., Germano, G., Mantovani, A., Allavena, P., Tumor-associated macrophages (TAM) as major players of the cancer-related inflammation. J Leukoc Biol 86 (2009), 1065–1073.
211. Soucek, L., Whitfield, J.R., Sodir, N.M., Masso-Valles, D., Serrano, E., Karnezis, A.N.,.. Evan, G.I., Inhibition of Myc family proteins eradicates KRas-driven lung cancer in mice. Genes Dev 27 (2013), 504–513.
212. Spets, H., Stromberg, T., Georgii-Hemming, P., Siljason, J., Nilsson, K., Jernberg-Wiklund, H., Expression of the bcl-2 family of pro- and anti-apoptotic genes in multiple myeloma and normal plasma cells: regulation during interleukin-6(IL-6)-induced growth and survival. Eur J Haematol 69 (2002), 76–89.
213. Spisek, R., Dhodapkar, M.V., Towards a better way to die with chemotherapy: role of heat shock protein exposure on dying tumor cells. Cell Cycle 6 (2007), 1962–1965.
214. Standiford, T.J., Kunkel, S.L., Lukacs, N.W., Greenberger, M.J., Danforth, J.M., Kunkel, R.G., Strieter, R.M., Macrophage inflammatory protein-1 alpha mediates lung leukocyte recruitment, lung capillary leak, and early mortality in murine endotoxemia. J Immunol 155 (1995), 1515–1524.
215. Stockmann, C., Doedens, A., Weidemann, A., Zhang, N., Takeda, N., Greenberg, J.I.,.. Johnson, R.S., Deletion of vascular endothelial growth factor in myeloid cells accelerates tumorigenesis. Nature 456 (2008), 814–818.
216. Subra, C., Grand, D., Laulagnier, K., Stella, A., Lambeau, G., Paillasse, M.,.. Record, M., Exosomes account for vesicle-mediated transcellular transport of activatable phospholipases and prostaglandins. J Lipid Res 51 (2010), 2105–2120.
217. Suematsu, S., Matsusaka, T., Matsuda, T., Ohno, S., Miyazaki, J., Yamamura, K.,.. Kishimoto, T., Generation of plasmacytomas with the chromosomal translocation t(12;15) in interleukin 6 transgenic mice. Proc Natl Acad Sci U S A 89 (1992), 232–235.
218. Sun, L., Zhang, Q., Li, Y., Tang, N., Qiu, X., CCL21/CCR7 up-regulate vascular endothelial growth factor-D expression via ERK pathway in human non-small cell lung cancer cells. Int J Clin Exp Pathol 8 (2015), 15729–15738.
219. Sun, X., Cheng, G., Hao, M., Zheng, J., Zhou, X., Zhang, J.,.. Wang, J., CXCL12/CXCR4/CXCR7 chemokine axis and cancer progression. Cancer Metastasis Rev 29 (2010), 709–722.
220. Swamydas, M., Ricci, K., Rego, S.L., Dreau, D., Mesenchymal stem cell-derived CCL-9 and CCL-5 promote mammary tumor cell invasion and the activation of matrix metalloproteinases. Cell Adh Migr 7 (2013), 315–324.
221. Takahashi, H., Ogata, H., Nishigaki, R., Broide, D.H., Karin, M., Tobacco smoke promotes lung tumorigenesis by triggering IKKbeta- and JNK1-dependent inflammation. Cancer Cell 17 (2010), 89–97.
222. Tan, M.C., Goedegebuure, P.S., Belt, B.A., Flaherty, B., Sankpal, N., Gillanders, W.E.,.. Linehan, D.C., Disruption of CCR5-dependent homing of regulatory T cells inhibits tumor growth in a murine model of pancreatic cancer. J Immunol 182 (2009), 1746–1755.
223. Tan, W., Zhang, W., Strasner, A., Grivennikov, S., Cheng, J.Q., Hoffman, R.M., Karin, M., Tumour-infiltrating regulatory T cells stimulate mammary cancer metastasis through RANKL-RANK signalling. Nature 470 (2011), 548–553.
224. Taylor, D.D., Gercel-Taylor, C., Lyons, K.S., Stanson, J., Whiteside, T.L., T-cell apoptosis and suppression of T-cell receptor/CD3-zeta by Fas ligand-containing membrane vesicles shed from ovarian tumors. Clin Cancer Res 9 (2003), 5113–5119.
225. Templeton, A.J., McNamara, M.G., Seruga, B., Vera-Badillo, F.E., Aneja, P., Ocana, A.,.. Amir, E., Prognostic role of neutrophil-to-lymphocyte ratio in solid tumors: a systematic review and meta-analysis. J Natl Cancer Inst, 106, 2014, dju124.
226. Terme, M., Ullrich, E., Aymeric, L., Meinhardt, K., Desbois, M., Delahaye, N.,.. Zitvogel, L., IL-18 induces PD-1-dependent immunosuppression in cancer. Cancer Res 71 (2011), 5393–5399.
227. Tosolini, M., Kirilovsky, A., Mlecnik, B., Fredriksen, T., Mauger, S., Bindea, G.,.. Galon, J., Clinical impact of different classes of infiltrating T cytotoxic and helper cells (Th1, th2, treg, th17) in patients with colorectal cancer. Cancer Res 71 (2011), 1263–1271.
228. Tu, T.C., Nagano, M., Yamashita, T., Hamada, H., Ohneda, K., Kimura, K., Ohneda, O., A chemokine receptor, CXCR4, which is regulated by hypoxia-inducible factor 2alpha, is crucial for functional endothelial progenitor cells migration to ischemic tissue and wound repair. Stem Cells Dev 25 (2016), 266–276.
229. Udono, H., Srivastava, P.K., Comparison of tumor-specific immunogenicities of stress-induced proteins gp96, hsp90, and hsp70. J Immunol 152 (1994), 5398–5403.
230. Uzan, B., Poglio, S., Gerby, B., Wu, C.L., Gross, J., Armstrong, F.,.. Pflumio, F., Interleukin-18 produced by bone marrow-derived stromal cells supports T-cell acute leukaemia progression. EMBO Mol Med 6 (2014), 821–834.
231. Vaday, G.G., Peehl, D.M., Kadam, P.A., Lawrence, D.M., Expression of CCL5 (RANTES) and CCR5 in prostate cancer. Prostate 66 (2006), 124–134.
232. Valcarcel, M., Carrascal, T., Crende, O., Vidal-Vanaclocha, F., IL-18 regulates melanoma VLA-4 integrin activation through a Hierarchized sequence of inflammatory factors. J Invest Dermatol 134 (2014), 470–480.
233. Valenti, R., Huber, V., Filipazzi, P., Pilla, L., Sovena, G., Villa, A.,.. Rivoltini, L., Human tumor-released microvesicles promote the differentiation of myeloid cells with transforming growth factor-beta-mediated suppressive activity on T lymphocytes. Cancer Res 66 (2006), 9290–9298.
234. Velasco-Velazquez, M., Jiao, X., De La Fuente, M., Pestell, T.G., Ertel, A., Lisanti, M.P., Pestell, R.G., CCR5 antagonist blocks metastasis of basal breast cancer cells. Cancer Res 72 (2012), 3839–3850.
235. Vetizou, M., Pitt, J.M., Daillere, R., Lepage, P., Waldschmitt, N., Flament, C.,.. Zitvogel, L., Anticancer immunotherapy by CTLA-4 blockade relies on the gut microbiota. Science 350 (2015), 1079–1084.
236. Viaud, S., Saccheri, F., Mignot, G., Yamazaki, T., Daillere, R., Hannani, D.,.. Zitvogel, L., The intestinal microbiota modulates the anticancer immune effects of cyclophosphamide. Science 342 (2013), 971–976.
237. Vilcek, J., Feldmann, M., Historical review: cytokines as therapeutics and targets of therapeutics. Trends Pharmacol Sci 25 (2004), 201–209.
238. Voronov, E., Reich, E., Dotan, S., Dransh, P., Cohen, I., Huszar, M.,.. Apte, R.N., Effects of IL-1 molecules on growth patterns of 3-MCA-induced cell lines: an interplay between immunogenicity and invasive potential. J Immunotoxicol 7 (2010), 27–38.
239. Waight, J.D., Hu, Q., Miller, A., Liu, S., Abrams, S.I., Tumor-derived G-CSF facilitates neoplastic growth through a granulocytic myeloid-derived suppressor cell-dependent mechanism. PLoS One, 6, 2011, e27690.
240. Walch-Ruckheim, B., Mavrova, R., Henning, M., Vicinus, B., Kim, Y.J., Bohle, R.M.,.. Smola, S., Stromal fibroblasts induce CCL20 through IL6/C/EBPbeta to support the recruitment of Th17 cells during cervical cancer progression. Cancer Res 75 (2015), 5248–5259.
241. Waldner, M.J., Foersch, S., Neurath, M.F., Interleukin-6—a key regulator of colorectal cancer development. Int J Biol Sci 8 (2012), 1248–1253.
242. Waldner, M.J., Neurath, M.F., Potential avenues for immunotherapy of colitis-associated neoplasia. Immunotherapy 4 (2012), 397–405.
243. Walmsley, S.R., Chilvers, E.R., Thompson, A.A., Vaughan, K., Marriott, H.M., Parker, L.C.,.. Whyte, M.K., Prolyl hydroxylase 3 (PHD3) is essential for hypoxic regulation of neutrophilic inflammation in humans and mice. J Clin Invest 121 (2011), 1053–1063.
244. Wang, K., Karin, M., The IL-23 to IL-17 cascade inflammation-related cancers. Clin Exp Rheumatol 33 (2015), S87–S90.
245. Wang, K., Kim, M.K., Di Caro, G., Wong, J., Shalapour, S., Wan, J.,.. Karin, M., Interleukin-17 receptor a signaling in transformed enterocytes promotes early colorectal tumorigenesis. Immunity 41 (2014), 1052–1063.
246. Wang, L., Yi, T., Kortylewski, M., Pardoll, D.M., Zeng, D., Yu, H., IL-17 can promote tumor growth through an IL-6-Stat3 signaling pathway. J Exp Med 206 (2009), 1457–1464.
247. Wang, S.W., Liu, S.C., Sun, H.L., Huang, T.Y., Chan, C.H., Yang, C.Y.,.. Tang, C.H., CCL5/CCR5 axis induces vascular endothelial growth factor-mediated tumor angiogenesis in human osteosarcoma microenvironment. Carcinogenesis 36 (2015), 104–114.
248. Ward, S.T., Li, K.K., Hepburn, E., Weston, C.J., Curbishley, S.M., Reynolds, G.M.,.. Adams, D.H., The effects of CCR5 inhibition on regulatory T-cell recruitment to colorectal cancer. Br J Cancer 112 (2015), 319–328.
249. Welte, T., Zhang, X.H., Interleukin-17 could promote breast cancer progression at several stages of the disease. Mediators Inflamm, 2015, 2015, 804347.
250. Wolf, D., Wolf, A.M., Rumpold, H., Fiegl, H., Zeimet, A.G., Muller-Holzner, E.,.. Marth, C., The expression of the regulatory T cell-specific forkhead box transcription factor FoxP3 is associated with poor prognosis in ovarian cancer. Clin Cancer Res 11 (2005), 8326–8331.
251. Wu, X., Cao, Y., Xiao, H., Li, C., Lin, J., Bazedoxifene as a novel GP130 inhibitor for pancreatic cancer therapy. Mol Cancer Ther, 2016, 10.1158/1535-7163.MCT-15-0921.
252. Xu, L., Xu, W., Qiu, S., Xiong, S., Enrichment of CCR6 + Foxp3 + regulatory T cells in the tumor mass correlates with impaired CD8 + T cell function and poor prognosis of breast cancer. Clin Immunol 135 (2010), 466–475.
253. Yamamoto, K., Utsunomiya, A., Tobinai, K., Tsukasaki, K., Uike, N., Uozumi, K.,.. Ueda, R., Phase I study of KW-0761, a defucosylated humanized anti-CCR4 antibody, in relapsed patients with adult T-cell leukemia-lymphoma and peripheral T-cell lymphoma. J Clin Oncol 28 (2010), 1591–1598.
254. Yang, P., Li, Q.J., Feng, Y., Zhang, Y., Markowitz, G.J., Ning, S.,.. Wang, X.F., TGF-beta-miR-34a-CCL22 signaling-induced Treg cell recruitment promotes venous metastases of HBV-positive hepatocellular carcinoma. Cancer Cell 22 (2012), 291–303.
255. Yu, H., Lee, H., Herrmann, A., Buettner, R., Jove, R., Revisiting STAT3 signalling in cancer: new and unexpected biological functions. Nat Rev Cancer 14 (2014), 736–746.
256. Yuan, M., Zhu, H., Xu, J., Zheng, Y., Cao, X., Liu, Q., Tumor-derived CXCL1 promotes lung cancer growth via recruitment of tumor-associated neutrophils. J Immunol Res, 2016, 2016, 6530410.
257. Zhang, L., Li, J., Li, L., Zhang, J., Wang, X., Yang, C.,.. Lin, P., IL-23 selectively promotes the metastasis of colorectal carcinoma cells with impaired Socs3 expression via the STAT5 pathway. Carcinogenesis 35 (2014), 1330–1340.
258. Zhang, N., Zeng, Y., Du, W., Zhu, J., Shen, D., Liu, Z., Huang, J.A., The EGFR pathway is involved in the regulation of PD-L1 expression via the IL-6/JAK/STAT3 signaling pathway in EGFR-mutated non-small cell lung cancer. Int J Oncol 49 (2016), 1360–1368.
259. Zhang, Y., Li, Y., Ma, Y., Liu, S., She, Y., Zhao, P.,.. Ye, L., Dual effects of interleukin-18: inhibiting hepatitis B virus replication in HepG2.2.15 cells and promoting hepatoma cells metastasis. Am J Physiol Gastrointest Liver Physiol 301 (2011), G565–G573.
260. Zhao, Y., Butler, E.B., Tan, M., Targeting cellular metabolism to improve cancer therapeutics. Cell Death Dis, 4, 2013, e532.
261. Zhou, L., Ivanov, I.I., Spolski, R., Min, R., Shenderov, K., Egawa, T.,.. Littman, D.R., IL-6 programs T(H)-17 cell differentiation by promoting sequential engagement of the IL-21 and IL-23 pathways. Nat Immunol 8 (2007), 967–974.
262. Zhou, S.L., Dai, Z., Zhou, Z.J., Chen, Q., Wang, Z., Xiao, Y.S.,.. Zhou, J., CXCL5 contributes to tumor metastasis and recurrence of intrahepatic cholangiocarcinoma by recruiting infiltrative intratumoral neutrophils. Carcinogenesis 35 (2014), 597–605.
263. Zhou, Y., Larsen, P.H., Hao, C., Yong, V.W., CXCR4 is a major chemokine receptor on glioma cells and mediates their survival. J Biol Chem 277 (2002), 49481–49487.
264. Zhu, P., Baek, S.H., Bourk, E.M., Ohgi, K.A., Garcia-Bassets, I., Sanjo, H.,.. Rose, D.W., Macrophage/cancer cell interactions mediate hormone resistance by a nuclear receptor derepression pathway. Cell 124 (2006), 615–629.
265. Zhu, Y.M., Webster, S.J., Flower, D., Woll, P.J., Interleukin-8/CXCL8 is a growth factor for human lung cancer cells. Br J Cancer 91 (2004), 1970–1976.
266. Zhu, Y.M., Woll, P.J., Mitogenic effects of interleukin-8/CXCL8 on cancer cells. Future Oncol 1 (2005), 699–704.
267. Zitvogel, L., Kepp, O., Kroemer, G., Decoding cell death signals in inflammation and immunity. Cell 140 (2010), 798–804.
268. Zou, W., Restifo, N.P., T(H)17 cells in tumour immunity and immunotherapy. Nat Rev Immunol 10 (2010), 248–256.